fluorodeoxyglucose f18 has been researched along with Seminoma in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (8.93) | 18.2507 |
| 2000's | 23 (41.07) | 29.6817 |
| 2010's | 20 (35.71) | 24.3611 |
| 2020's | 8 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, C; Barthelemy, P; Bompas, E; Chevreau, C; Culine, S; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Grimaldi, S; Gross-Goupil, M; Helissey, C; Lacourtoisie, SA; Ladoire, S; Laguerre, B; Loriot, Y; Mahammedi, H; Massard, C; Texier, M; Thiery-Vuillemin, A | 1 |
| Conduit, C; Goad, J; Hofman, MS; Koh, TT; Lawrentschuk, N; Lewin, JH; Tai, KH; Toner, GC; Tran, B | 1 |
| Mottet, N; Tremeau, L | 1 |
| Al-Kandari, F; Ghanem, M; Marafi, F; Rasheed, R; Usmani, S | 1 |
| Chen, Y; Liu, H | 1 |
| Alessi, A; Bandini, M; Calareso, G; Colecchia, M; Farè, E; Giannatempo, P; Marandino, L; Necchi, A; Padovano, B; Raggi, D; Serafini, G | 1 |
| González, E; Martí, A; Morón, S; Rojas, J | 1 |
| Agrawal, A; Bakshi, G; Carlton, J; Joshi, A; Karmakar, S; Krishnatry, R; Menon, S; Murthy, V; Noronha, V; Pal, M; Prabhash, K; Prakash, G; Rangarajan, V | 1 |
| Han, EJ; Lee, J; O, JH; Park, G | 1 |
| Gorin, MA; Joice, GA; Pierorazio, PM; Rowe, SP | 1 |
| Colling, CW; Robinson, RA; Vaena, DA; Wudhikarn, K | 1 |
| Allegri, V; Ambrosini, V; Berselli, A; Cricca, A; Domenico, R; Fanti, S; Martoni, A; Nanni, C; Nicolini, S; Rubello, D; Zucchini, G | 1 |
| Bilen, MA; Guo, CC; Hariri, H; Kuban, DA; Leon, C; Pisters, LL; Tu, SM | 1 |
| Li, MM; Li, YY; Liu, L; Ma, XL; Zhang, BL; Zhao, JY | 1 |
| Deroose, CM; Gheysens, O; Lips, N; Moerman, P; Peetermans, WE; Schöffski, P; Slabbaert, K; Vancleynenbreugel, B | 1 |
| Annunziata, S; Bertagna, F; Caldarella, C; Giovanella, L; Sadeghi, R; Treglia, G | 1 |
| Liepe, K | 1 |
| Albers, P; Decoene, J; Winter, C | 1 |
| Chua, S; Cook, GJ; Dearnaley, DP; Horwich, A; Huddart, RA; Sohaib, A | 1 |
| Richie, JP | 1 |
| Alessi, A; Crippa, F; Giannatempo, P; Mariani, L; Miceli, R; Necchi, A; Nicolai, N; Padovano, B; Raggi, D; Salvioni, R; Serafini, G; Tana, S | 1 |
| Hashizume, A; Kawai, M; Kishida, T; Mizuno, N | 1 |
| Ando, M; Fujiwara, Y; Hirata, T; Iwasa, S; Katsumata, N; Kouno, T; Nakano, E; Ono, M; Shimizu, C; Tamura, K; Yonemori, K; Yunokawa, M | 1 |
| Cathomas, R; Mueller, J; Putora, PM; Schmidt, F; Stallmach, T | 1 |
| Jentzmik, F; Müller, J; Schrader, AJ; Schrader, M | 1 |
| Fukui, I; Hayasaka, K; Koyama, M | 1 |
| Isowa, N; Sakaguchi, Y | 1 |
| Chmielowska, E; Chłosta, P; Drewa, T; Jasiński, M; Jóźwicki, W; Kamecki, K; Kraśnicki, K; Małkowski, B; Mikołajczak, W; Petrus, A; Pietrzak, T; Siekiera, J; Wronczewski, A | 1 |
| Albiges, L; Bellmunt, J; Bonardel, G; Boutros, C; Fizazi, K; Loriot, Y; Massard, C; Wagner, M | 1 |
| Agoston, P; Bodrogi, I; Esik, O; Lengyel, E; Lengyel, Z; Márián, T; Sáfrány, G; Székely, J; Trón, L; Vönöczky, K | 1 |
| Damgaard, K; Daugaard, G; Eigtved, A; Højgaard, L; Lassen, U; Rørth, M | 1 |
| Bourguet, P | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kollmannsberger, C; Oechsle, K; Pfannenberg, AC; Vontheim, R | 1 |
| Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Kletter, K; Lang, A; Oechsle, K; Pont, J; Sellner, F; Stoiber, F | 1 |
| Baillet, G; Moretti, JL; Tamgac, F; Tofighi, M; Weinmann, P | 1 |
| Lenzo, NP; Moschilla, G; Patrikeos, A | 1 |
| Lincke, T; Sabri, O; Scheid, R; Voltz, R; von Cramon, DY | 1 |
| Ballok, Z; Bolton, DM; Davis, ID; Hannah, A; Hicks, RJ; Johns Putra, L; Lawrentschuk, N; Poon, A; Putra, LJ; Scott, AM; Tauro, A | 1 |
| Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Dudczak, R; Karanikas, G; Kletter, K; Pont, J; Szabó, M | 1 |
| Arzumanov, AA; Granov, AM; Karelin, MI; Kostenikov, NA; Ryzhkova, DV; Shkol'nik, MI; Stanzhevskiĭ, AA; Tlostanova, MS | 1 |
| Gilligan, T | 1 |
| Fujimoto, K; Hirao, Y; Hirayama, A; Matsushita, C; Miyake, M; Nonomura, A; Takashima, K; Tanaka, M | 1 |
| Ali, I; Bottger, B; Gupta, SM; Johns, W | 1 |
| Cerny, T; Gillessen, S; Joerger, M; Klaeser, B; Kluckert, T; von Rohr, L | 1 |
| Laing, R; Nam, H; Smith, S | 1 |
| Cronin, BF; Flower, MA; Horwich, A; McCready, VR; Ott, RJ; Pratt, BE; Wilson, CB; Young, HE | 1 |
| Bachor, R; Gropengiesser, F; Hautmann, RE; Kocher, F; Reske, SN | 1 |
| Adam, G; Buell, U; Cremerius, U; Effert, PJ; Jakse, G; Sabri, O; Wagenknecht, G; Zimmy, M | 1 |
| Conti, PS; Muggia, FM | 1 |
| Ackermann, R; Fürst, G; Gerharz, CD; Müller-Gärtner, HW; Müller-Mattheis, V; Reinhardt, M; Vosberg, H | 1 |
| Hain, SF; Huddart, RA; Leslie, MD; O'Doherty, MJ; Partridge, SE; Timothy, AR | 1 |
| Hain, SF; Harper, PG; Huddart, RA; Leslie, MD; O'Doherty, MJ; Timothy, AR | 1 |
| Foehrenbach, H; Lumbroso, J; Maszelin, P; Merlet, P; Syrota, A; Theodore, C | 1 |
| Becherer, A; Bokemeyer, C; De Santis, M; Dittrich, C; Dohmen, BM; Kletter, K; Oechsle, K; Pont, J; Stoiber, F | 1 |
| Avril, N; Breul, J; Hartung, R; Hofer, C; Kübler, H | 1 |
| Bares, R; Bokemeyer, C; Claussen, CD; Dohmen, BM; Kanz, L; Kollmannsberger, C; Oechsle, K; Pfannenberg, A | 1 |
10 review(s) available for fluorodeoxyglucose f18 and Seminoma
| Article | Year |
|---|---|
[Management of residual masses of testis germ cell tumors].
Topics: Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Male; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Radiopharmaceuticals; Seminoma; Testicular Neoplasms | 2020 |
Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
Topics: Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Molecular Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Space; Seminoma; Testicular Neoplasms | 2018 |
Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature.
Topics: Adult; Chemoradiotherapy; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
Topics: Area Under Curve; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Odds Ratio; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: systematic review and meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Male; Monitoring, Physiologic; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms | 2014 |
[Assessment of residual tumours after systemic treatment of metastatic seminoma: ¹⁸F-2-fluoro-2-deoxy-D-glucose positron emission tomography - meta-analysis of diagnostic value].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Treatment Outcome; Young Adult | 2011 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urologic Neoplasms | 2003 |
[The interest of 18FDG-PET in the management of testicular cancer].
Topics: Adolescent; Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis.
Topics: Adult; Electroencephalography; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Temporal Lobe; Teratoma; Testicular Neoplasms | 2004 |
Diagnosis and monitoring of urological tumors using positron emission tomography.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms | 2001 |
8 trial(s) available for fluorodeoxyglucose f18 and Seminoma
| Article | Year |
|---|---|
The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome | 2022 |
Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Aged; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Secondary Prevention; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting | 2003 |
FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals.
Topics: Abdomen; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiographic Image Enhancement; Radiography, Abdominal; Radiography, Thoracic; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Thorax; Tomography, Spiral Computed | 2005 |
Fluorodeoxyglucose PET in the initial staging of germ cell tumours.
Topics: Adolescent; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Germinoma; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed | 2000 |
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed | 2000 |
[Fluorodeoxyglucose (FDO) positron emission tomography (PET) in testicular germ cell tumors in adults: preliminary French clinical evaluation, development of the technique and its clinical applications].
Topics: Adult; Equipment Design; Fluorodeoxyglucose F18; France; Germinoma; Humans; Male; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed | 2000 |
Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2001 |
Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Salvage Therapy; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2002 |
38 other study(ies) available for fluorodeoxyglucose f18 and Seminoma
| Article | Year |
|---|---|
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2022 |
Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Young Adult | 2020 |
Mediastinal seminoma mimicking invasive thymoma on
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Thymoma; Thymus Neoplasms | 2021 |
Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Seminoma; Testicular Neoplasms | 2021 |
Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia
Topics: Adult; Aged; Asymptomatic Diseases; Betacoronavirus; Carcinoma, Signet Ring Cell; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms; Pandemics; Pleural Effusion; Pneumonia, Viral; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Seminoma; Stomach Neoplasms | 2020 |
Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach.
Topics: Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms | 2021 |
FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome.
Topics: Androgen-Insensitivity Syndrome; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Seminoma; Testicular Neoplasms; Young Adult | 2017 |
Solitary bony metastasis in seminoma.
Topics: Biomarkers, Tumor; Bone Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Contrast Media; Fluorodeoxyglucose F18; Humans; Humerus; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Orchiectomy; Positron-Emission Tomography; Radiotherapy, Adjuvant; Rotator Cuff; Seminoma; Shoulder Impingement Syndrome; Testicular Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-FDG PET/CT impact on testicular tumours clinical management.
Topics: Adolescent; Adult; Aged; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2014 |
False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Seminoma; Testicular Neoplasms | 2015 |
False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms | 2015 |
The role of 18F-FDG PET/CT in the management of testicular cancers.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 2015 |
Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
Topics: Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2015 |
Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tissue Distribution; Treatment Outcome; Tumor Burden | 2016 |
[A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Treatment Outcome | 2016 |
Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Have you ever heard of hibernoma? A rare but important pitfall in FDG-PET/CT.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Lipoma; Lymphatic Metastasis; Male; Orchiectomy; Positron-Emission Tomography; Seminoma; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
FDG PET imaging in a patient with primary seminoma of the prostate.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Seminoma; Tomography, X-Ray Computed | 2011 |
Successful resection of mediastinal seminoma evaluated the response to induction chemotherapy with fluorodeoxyglucose-positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Mediastinal Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tomography, X-Ray Computed | 2012 |
Can we rely on PET in the follow-up of advanced seminoma patients?
Topics: Antineoplastic Agents; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasm, Residual; Poland; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
False positive 2-(18)Fluroro-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with disseminated seminoma and post-chemotherapy residual masses.
Topics: Adult; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Seminoma | 2013 |
A PET study on the characterization of partially reversible radiogenic lower motor neurone disease.
Topics: Adult; Cobalt Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Motor Neuron Disease; Radioisotope Teletherapy; Radiopharmaceuticals; Recovery of Function; Seminoma; Sodium Channels; Testicular Neoplasms; Tomography, Emission-Computed | 2002 |
[Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chorionic Gonadotropin, beta Subunit, Human; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Germinoma; Humans; Karnofsky Performance Status; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Patient Selection; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial.
Topics: Austria; Clinical Trials as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Germany; Humans; Male; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 2004 |
Diffuse splenic metastases from seminoma visualized on FDG PET.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Splenic Neoplasms; Testicular Neoplasms; Tomography, Emission-Computed | 2004 |
18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy.
Topics: Adult; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Seminoma | 2004 |
[Positron emission tomography in oncourology].
Topics: Adolescent; Adult; Aged; Carcinoma, Embryonal; Carcinoma, Renal Cell; Choriocarcinoma; Data Interpretation, Statistical; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Testis | 2005 |
Republication of SEMPET trial data?
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Radiography, Abdominal; Radiopharmaceuticals; Seminoma; Testicular Neoplasms | 2006 |
[A case of primary and solitary bone metastasis of testicular seminoma after orchiectomy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Etoposide; Fluorodeoxyglucose F18; Humans; Male; Orchiectomy; Peplomycin; Positron-Emission Tomography; Seminoma; Testicular Neoplasms | 2005 |
Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
Topics: Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Radiopharmaceuticals; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed | 2007 |
Increased pulmonary FDG uptake in bleomycin-associated pneumonitis.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonia; Positron-Emission Tomography; Seminoma; Testicular Neoplasms; Testis; Tomography, X-Ray Computed | 2007 |
A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Ink; Lymph Nodes; Lymphatic Metastasis; Male; Orchiectomy; Positron-Emission Tomography; Radiopharmaceuticals; Seminoma; Tattooing; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed | 2007 |
Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management.
Topics: Abdominal Neoplasms; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Seminoma; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed | 1995 |
[Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results].
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Carcinoma, Renal Cell; Combined Modality Therapy; Deoxyglucose; Equipment Design; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Postoperative Complications; Salvage Therapy; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Urinary Bladder Neoplasms; Urogenital Neoplasms | 1995 |
FDG PET for detection and therapy control of metastatic germ cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Germinoma; Humans; Male; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?
Topics: False Positive Reactions; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Sarcoidosis; Seminoma; Testicular Neoplasms; Tomography, Emission-Computed | 1998 |
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Topics: Adult; Biomarkers, Tumor; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Seminoma; Sensitivity and Specificity; Testicular Neoplasms; Tomography, Emission-Computed | 1998 |